The pioneering 3D-printed microneedles are for inner ear drug delivery and diagnostics. Image: Haystack Medical. US company Haystack Medical has received a grant to further develop its ultra-sharp microneedle platform for direct access to the inner ear....
Continue reading at Hearing Practitioner Australia
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is an early-stage grant award for a device still in development; no clinical data or regulatory approval exists yet.
If successfully developed, microneedle-based inner ear access could open a less invasive route for drug delivery and diagnostics, potentially transforming treatment of conditions like Ménière's disease, sudden sensorineural hearing loss, and ototoxicity monitoring.
- 01Haystack Medical (US) has secured a grant to advance its 3D-printed ultra-sharp microneedle platform.
- 02The technology targets direct drug delivery and diagnostics for the inner ear.
- 03Microneedles offer a potential minimally invasive alternative to current intratympanic injection techniques.
- 04The platform is still in development — no clinical trial data or regulatory clearance has been reported.
- 05Grant funding signals early-stage institutional confidence but does not confirm clinical viability.
Haystack Medical's 3D-printed microneedle platform can enable direct inner ear drug delivery and diagnostics.
press releaseunclearThe microneedles are described as 'ultra-sharp', implying superior tissue penetration with minimal trauma.
press releaseunclear